Rajesh Solanki - Concepedia

Author

Rajesh Solanki

Also Known As

Krishan Kumar Mathur, R N Solanki, R Solanki, R. Solanki, RK Solanki RK Solanki, Rahul Solanki, Rajesh N Solanki, Rajesh N. Solanki, Rajesh S Solanki, Rajesh Solanki

Publications

672

Citations

H-Index

Concepts

All Affiliations

B.J. Medical College National Institute of Research in Tuberculosis MRC Clinical Trials Unit at UCL University College London Liverpool School of Tropical Medicine

About

Rajesh Solanki is an author at B.J. Medical College specializing in medicine, tuberculosis prevention, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	6	233
2	Social Sciences	1	1	46
3	Epidemiology	1	1	12
4	Family Medicine	1	1	46
5	Geriatrics	1	1	46

Rajesh Solanki

Publications

492

Citations

H-Index

Page 1

	Year	Citations
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial Ruth Goodall, Sarah Meredith, Andrew Nunn, The Lancet Pulmonary TuberculosisRifampicin-resistant TuberculosisTuberculosis PreventionTuberculosisPharmacotherapy	2022	134
Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis Chandrasekaran Padmapriyadarsini, Vikram Vohra, Anuj Bhatnagar, Clinical Infectious Diseases	2022	108
A Multi-Site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens Neeraj Raizada, Kuldeep Singh Sachdeva, Devendra Singh Chauhan, PLoS ONE	2014	58
Psychological well-being and burden in caregivers of patients with schizophrenia Aditya Gupta, Rajesh Solanki, GD Koolwal, International Journal of Medical Science and Public Health Quality Of LifeFamily MedicineIndian StudiesPsychiatryGeriatrics	2014	46
Treatment outcome of andardized regimen in patients with multidrug resistant tuberculosis Kalpesh Kumar Jain, Mira Desai, Rajesh Solanki, Journal of Pharmacology and Pharmacotherapeutics	2014	40
Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India Vishal Mishra, Krunal Prajapati, Mira Desai, International Journal of Mycobacteriology	2017	24
Early treatment outcome of bedaquiline plus optimised background regimen in drug resistant tuberculosis patients Sandip V. Barvaliya, Mira Desai, Jigar Panchal, Indian Journal of Tuberculosis Tuberculosis PreventionPharmacologyOptimised Background RegimenTreatment OptionTuberculosis	2020	19
Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial Laura Roșu, Jason Madan, Ewan Tomeny, The Lancet Global Health	2022	17
Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis Chandrasekaran Padmapriyadarsini, Rajesh Solanki, Shanmugam M. Jeyakumar, Antibiotics	2023	13
Impact of adverse drug reaction of first line anti - tuberculous drugs on treatment outcome of tuberculosis under revised national tuberculosis control programme Amit R. Dedun, Ghanshyam Borisagar, Rajesh Solanki International Journal of Advances in Medicine Tuberculosis PreventionRntcp CentreTuberculous DrugsPharmacotherapyAntimicrobial Chemotherapy	2017	12

Page 1